Voyager Therapeutics Inc (VYGR) stock news · rev $40.4M
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
This VYGR news page leads with what Voyager Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for VYGR yet. We will not pad this page with generic market recap.
Latest reported VYGR revenue for 2025-12-31 was $40.4M. Net income was -$119.7M. Revenue was down 49.5% from 2024-12-31 to 2025-12-31. VYGR currently screens at market cap $225.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VYGR stock page; for the tape open the quote page.
VYGR stock news FAQ
What are VYGR's latest revenue and net income?
Latest cached Voyager Therapeutics Inc (VYGR) revenue for Dec 31, 2025 was $40.4M. Net income was -$119.7M. Statements: https://lician.com/financials/vygr
How did VYGR revenue change from the prior cached period?
Cached Voyager Therapeutics Inc (VYGR) revenue was down 49.5% from $80.0M (Dec 31, 2024) to $40.4M (Dec 31, 2025). Statements: https://lician.com/financials/vygr
What is VYGR's market cap?
Voyager Therapeutics Inc (VYGR) market cap is $225.4M on the latest cached fundamentals snapshot.
What kind of company is VYGR?
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Where is VYGR stock news listed?
Cached stock news for Voyager Therapeutics Inc (VYGR) is listed at https://lician.com/news/vygr. Filings: https://lician.com/sec/vygr
Not investment advice.